262 related articles for article (PubMed ID: 26367086)
1. Should patients with optic neuritis be treated with steroids?
Mackay DD
Curr Opin Ophthalmol; 2015 Nov; 26(6):439-44. PubMed ID: 26367086
[TBL] [Abstract][Full Text] [Related]
2. Evolving management of optic neuritis and multiple sclerosis.
Arnold AC
Am J Ophthalmol; 2005 Jun; 139(6):1101-8. PubMed ID: 15953446
[TBL] [Abstract][Full Text] [Related]
3. Optic neuritis in multiple sclerosis.
Chan JW
Ocul Immunol Inflamm; 2002 Sep; 10(3):161-86. PubMed ID: 12789593
[TBL] [Abstract][Full Text] [Related]
4. Management of optic neuritis as a clinically first event of multiple sclerosis.
Kale N
Curr Opin Ophthalmol; 2012 Nov; 23(6):472-6. PubMed ID: 23014264
[TBL] [Abstract][Full Text] [Related]
5. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.
Optic Neuritis Study Group
Neurology; 1997 Nov; 49(5):1404-13. PubMed ID: 9371930
[TBL] [Abstract][Full Text] [Related]
6. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
7. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M;
Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of optic neuritis].
van der Worp HB; van Gijn J; Plant GT
Ned Tijdschr Geneeskd; 2004 Jan; 148(2):61-5. PubMed ID: 14753126
[TBL] [Abstract][Full Text] [Related]
9. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials.
Brusaferri F; Candelise L
J Neurol; 2000 Jun; 247(6):435-42. PubMed ID: 10929272
[TBL] [Abstract][Full Text] [Related]
10. Acute demyelinating optic neuritis.
Foroozan R; Buono LM; Savino PJ; Sergott RC
Curr Opin Ophthalmol; 2002 Dec; 13(6):375-80. PubMed ID: 12441840
[TBL] [Abstract][Full Text] [Related]
11. Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial.
Moss HE; Gao W; Balcer LJ; Joslin CE
JAMA Ophthalmol; 2014 Apr; 132(4):421-7. PubMed ID: 24557028
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial.
Rolak LA; Beck RW; Paty DW; Tourtellotte WW; Whitaker JN; Rudick RA
Neurology; 1996 Feb; 46(2):368-72. PubMed ID: 8614496
[TBL] [Abstract][Full Text] [Related]
13. Management of optic neuritis in Ireland: a survey comparing the management practices of acute demyelinating optic neuritis amongst ophthalmologists and neurologists in Ireland.
Kobayter L; Chetty S
Ir J Med Sci; 2019 Feb; 188(1):277-282. PubMed ID: 29693233
[TBL] [Abstract][Full Text] [Related]
14. Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis.
Lai C; Chang Q; Tian G; Wang J; Yin H; Liu W
PLoS One; 2015; 10(10):e0141005. PubMed ID: 26485719
[TBL] [Abstract][Full Text] [Related]
15. Optic neuritis: a review.
Shams PN; Plant GT
Int MS J; 2009 Sep; 16(3):82-9. PubMed ID: 19878630
[TBL] [Abstract][Full Text] [Related]
16. Association of Individual-Level Factors With Visual Outcomes in Optic Neuritis: Secondary Analysis of a Randomized Clinical Trial.
De Lott LB; Burke JF; Andrews CA; Costello F; Cornblath WT; Trobe JD; Lee PP; Kerber KA
JAMA Netw Open; 2020 May; 3(5):e204339. PubMed ID: 32379333
[TBL] [Abstract][Full Text] [Related]
17. Optic neuritis.
Clark D; Kebede W; Eggenberger E
Neurol Clin; 2010 Aug; 28(3):573-80. PubMed ID: 20637989
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin and interferon: successful treatment of optic neuritis in pediatric multiple sclerosis.
Spalice A; Properzi E; Lo Faro V; Acampora B; Iannetti P
J Child Neurol; 2004 Aug; 19(8):623-6. PubMed ID: 15605474
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute demyelinating optic neuritis.
Balcer LJ; Galetta SL
Semin Ophthalmol; 2002 Mar; 17(1):4-10. PubMed ID: 15513449
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis on steroids.
Johnson MS; Lee MS; Younge BR; Purvin V
Surv Ophthalmol; 2010; 55(5):460-6. PubMed ID: 20347108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
